Keywords: Mylan, Generic Lipitor, Atorvastatin, Europe, Financial guidance, Share buy-back

Mylan starts selling generic Lipitor in Europe; to buy back shares

Article | 14 May 2012

Print This

US generic drug major Mylan’s (Nasdaq: MYL) shares 2.2% to $21.55 in morning last Friday after the company revealed that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in